Skip to Main content Skip to Navigation
Journal articles

Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes

Abstract : A structure-based virtual screening of over 400,000 small molecules against the constitutive proteasome activity followed by in vitro assays led to the discovery of a family of proteasome inhibitors with a sulfonyl piperazine scaffold. Some members of this family of small non-peptidic inhibitors were found to act selectively on the β2 trypsin-like catalytic site with a preference for the immunoproteasome β2i over the constitutive proteasome β2c, while some act on the β5 site and post-acid site β1 of both, the immunoproteasome and the constitutive proteasome. Anti-proliferative and anti-invasive effects on tumor cells were investigated and observed for two compounds. We report novel chemical inhibitors able to interfere with the three types of active centers of both, the immuno- and constitutive proteasomes. Identifying and analyzing a novel scaffold with decorations able to shift the binders’ active site selectivity is essential to design a future generation of proteasome inhibitors able to distinguish the immunoproteasome from the constitutive proteasome.
Complete list of metadatas

Cited literature [53 references]  Display  Hide  Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01459714
Contributor : Joëlle Vidal <>
Submitted on : Friday, March 24, 2017 - 11:09:20 AM
Last modification on : Thursday, July 30, 2020 - 3:11:55 AM
Long-term archiving on: : Sunday, June 25, 2017 - 1:19:14 PM

File

14428-214561-3-PB.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Bruno O. Villoutreix, Abdel-Majid Khatib, Yan Cheng, Maria A. Miteva, Xavier Maréchal, et al.. Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes. Oncotarget, Impact journals, 2017, 8 (6), pp.10437-10449. ⟨10.18632/oncotarget.14428⟩. ⟨hal-01459714⟩

Share

Metrics

Record views

442

Files downloads

684